\
&
Contact us
\
&
Contact us
Partnership website: https://www.clean-hydrogen.europa.eu/index_en
As an institutionalised public-private partnership, Clean Hydrogen Joint Undertaking (JU) brings together the European Commission (the public sector), Hydrogen Europe and Hydrogen Europe Research (representing the hydrogen industries and hydrogen research community respectively) so as to bring together as many relevant actors as possible across the whole clean hydrogen value chain. It considers all sectors of the economy, but especially the hard-to-abate ones like transport and heavy industry.
In support of the European Green Deal, the Clean Hydrogen JU aims to accelerate development and deployment of European clean hydrogen technologies, contributing to a sustainable, decarbonised and fully integrated energy system. It contributes to the European climate neutrality goal by producing noticeable, quantifiable results towards the development and scaling up of hydrogen applications. This will help develop a number of hydrogen technologies, which are currently either not competitive or have a low technology readiness level, but are expected to contribute to the 2030 energy and climate targets and most importantly make the goal possible of climate neutrality by 2050.
The EU will support the Clean Hydrogen JU with €1 billion euro for the period 2021-2027, complemented by at least an equivalent amount of private investment (from the private members of the partnership), raising the total budget to above €2 billion euro.
As an institutionalised partnership, Clean Hydrogen JU has its own work programmes.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
